| P/E (FY) | — | Sales (TTM) | $1.5M |
| Earnings (TTM) | -$12.3M | ROE | −225.62% |
| Net Margin | −994.48% | ROIC | — |
| Debt / Equity | — | TD / EBITDA | — |
| EPS Growth 3Y | — | Sales Growth 3Y | — |
| Market Cap | $40.9M | Trading Days | 1227 |
| 52W High | 1.45 |
| 52W Low | 0.70 |
| % Off High | −37.43% |
| YTD | 8.01% | 1Y | −27.42% |
| 3Y | −53.47% | Since incept. (ann.) | −35.28% |
All Other Segments 100%
| Ann. Volatility (1Y) | 80.54% | Ann. Volatility (3Y) | 97.91% |
| Sharpe (1Y) | −0.00 | Sharpe (3Y) | 0.21 |
| Max Drawdown (1Y) | −45.30% | Max Drawdown (3Y) | −72.85% |
| Beta (3Y, vs SPY) | 2.05 |
| Ticker | Name | Mkt cap | P/E |
|---|---|---|---|
| FLNA | FILANA THERAPEUTICS, INC. | $42.7M | — |
| PDSB | PDS Biotechnology Corp | $38.5M | — |
| EDSA | Edesa Biotech, Inc. | $44.2M | — |
| HYPD | HYPERION DEFI, INC. | $36.7M | — |
| GRCE | Grace Therapeutics, Inc. | $36.6M | — |
| MCRB | Seres Therapeutics, Inc. | $46.0M | 7.5 |
| BHST | BIOHARVEST SCIENCES INC. | $46.2M | — |
| IBO | IMPACT BIOMEDICAL INC. | $46.4M | — |
| TCRT | Alaunos Therapeutics, Inc. | $46.4M | — |
| MIRA | MIRA PHARMACEUTICALS, INC. | $35.3M | — |
| NNVC | NANOVIRICIDES, INC. | $34.9M |
| — |
| GOSS | Gossamer Bio, Inc. | $48.1M | — |
